Advances in ICU Recovery: The Role of Red Light Therapy
Share
A recent study has shed light on the potential benefits of photobiomodulation therapy (PBMT) using low-intensity light-emitting diodes (LEDs) for patients in intensive care units (ICUs). This research provides valuable insights into how this therapy might improve patient outcomes in critical care settings.
In this study, the red light therapy employed 635nm and 880nm wavelengths to aid in recovery by boosting cellular energy production, reducing inflammation, and promoting healing.
Study Overview
The study was a randomized, triple-blind, sham-controlled trial conducted in an ICU with 60 participants. The patients were divided into two groups: one receiving active RLTÂ and the other receiving a sham treatment. Here are the key details:
-
Treatment Protocol:Â RLT was administered daily for 15 minutes using 264 LEDs. The treatment areas included the thighs, legs, arms, and forearms, delivering a total energy of 2,073.6 Joules per session.
-
Findings:
- ICU Stay: The average length of ICU stay was reduced by about 30% in the PBMT group.
- Muscle Strength: There was a 12% improvement in muscle strength among those receiving PBMT.
- Mobility: The PBMT group saw a 255% increase in mobility scores.
The study suggests that RLT may offer benefits such as reduced ICU stays, improved muscle strength, and enhanced mobility. These findings could make PBMT a valuable addition to ICU treatment protocols, providing a non-invasive option to support recovery.
Source: Wiley Online Library